Your selection
Research, Innovation, Patient care, Education / 18.06.2025
Students from Freie Universität Berlin visited the Campus Berlin-Buch

Visiting the Campus Berlin-Buch: Master's students in Biology at Freie Universität Berlin learned about career opportunities and start-ups at the BiotechPark Berlin-Buch on June 11, 2025.
During a tour of the campus with Campus Manager Dr. Ulrich Scheller, they were first given an overview of the closely cooperating research institutions and biotech companies as well as the location of future innovation Berlin-Buch, whose profile focuses on biomedicine and health.
Dr. Uwe Lohmeier, Head of the Berlin BioScience Academy, and Trendelina Rrustemi, Senior Scientist at Alithea Biotechnology GmbH, gave an insight into their career paths at the Career Panel Talk in the BerlinBioCube start-up center building. Dr. Lohmeier explained the development opportunities offered by the Berlin BioScience Academy (BBA).
Trendelin Rrustemi presented her start-up Alithea Biotechnology GmbH. It offers pioneering HLA peptide characterization with innovative immunopeptidomics, highly sensitive mass spectrometry and applied AI.
The students were then given an insight into the start-ups CUTANEON - Skin & Hair Innovations GmbH, Cultimate Foods GmbH and FyoniBio GmbH
The BiotechPark on the Campus Berlin-Buch is one of the leading technology parks in Germany. Buch has been renowned for its clinics and cutting-edge research for around 100 years and is now one of the largest biomedical locations in Germany.
The Berlin BioScience Academy (BBA), formerly known as "Gläsernes Labor Akademie (GLA)", supports young scientists throughout Germany in their professional orientation and entry into the pharmaceutical and biotechnology industry.
www.glaesernes-labor-akademie.de
Overview News
News Buch Berlin
A potential new drug for stiff hearts
Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In “Cardiovascular Research,” hi...
more ...Volker Haucke receives the Ernst Schering Prize 2025
The Ernst Schering Prize 2025, endowed with 50.000 euros, is awarded to Prof. Dr. Volker Haucke, Director at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Professor of Molecula...
more ...Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, has received marketing authorization in Japan ...
more ...Events Buch Berlin
30.10.2025, 17:00
Talk im Cube: CROs IN DIAGNOSTICS AND THERAPEUTICS DEVELOPMENT
We continue the Talks in the Cube with another expert discussion – the last event for 2025 focusses on Strategies to optimize the cooperation between the sponsor and Contract Research Organizations (C...
more ...04.11.2025, 16:00
Kryo-Elektronenmikroskopie: Tiefgekühlte Proben ermöglichen das Verständnis biologischer Mechanismen
Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch. Für Lehrkräfte, Schülerinnen und Schüler sowie Interessierte.
more ...05.11.2025, 14:00
Einladung zur Vorlesung: Neurobiologie - Forschung und neue Therapieansätze
Fortbildungsveranstaltung der Neurowissenschaftlichen Gesellschaft e.V. im Rahmen der Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch
more ...